From Persuasion to Justification: Retail in a GLP-1 World

By Josh Tilley, Brand Strategy Director, Initials CX

GLP-1s are a shift in consumer decision-making hiding in plain sight.

Much of the conversation still treats them as a category problem – something for food and drink brands to manage before it reaches the shelf, but the implications go much further. Retail sales don’t run on categories – they run on decision. Whether that’s what gets picked up, what gets justified, or what makes it into the basket. And increasingly, those same decisions are shaping how consumers interact with food and drink across supermarkets, restaurants and bars alike.

We’re already seeing early signs of this impact. GLP-1 users spend around 14% less on their weekly shop than before, while four in ten GLP-1 users say they are visiting restaurants less often, with almost half reporting they drink less alcohol.

Taken together, these aren’t isolated behavioural changes. They’re signals that consumer demand itself is beginning to shift.

From stimulation to selection

For decades, retail has been optimised around stimulation. End-of-aisle displays, multibuy offers and carefully engineered layouts have all been designed to encourage incremental purchase under the same underlying assumption: if you put more in front of people, they will buy more.

GLP-1s fundamentally disrupt that model.

When hunger is reduced and “food noise” (that intrusive mental chatter around eating, cravings and guilts) quietens, the instinct to add just one more item begins to fade. Consumers arrive with clearer intent, making fewer detours and leaving with smaller, more considered baskets. And in that context, retail shifts from being a game of persuasion to one of justification. Products and categories now have to earn their place in the basket, rather than rely on visibility alone.

The most immediate impact is a contraction in basket size. As consumers buy fewer items, each choice carries more weight. Shoppers are placing a greater emphasis on what a product delivers – whether that’s nutritional value, functional benefit, genuine enjoyment (or all three).

That dynamic is beginning to ripple through the fundamentals of retail. Mass ranges are becoming harder to justify at their current scale, particularly where duplication exists across brands and formats. And as demand consolidates around fewer, more intentional choices, there’s a growing case for tighter, more curated assortments that prioritise clarity over abundance.

Beyond the basket

The same behavioural shift is beginning to reshape hospitality. Unlike grocery retail, the challenge isn’t simply what ends up on the plate or in the glass. It’s whether they’re being ordered in the first place.

Reduced restaurant visits, lower alcohol consumption and smaller orders all point towards fewer dining occasions overall. More significantly, studies suggest these behaviours often persist even after consumers stop taking the medication, suggesting habits are changing for longer than the prescription itself. This could have significant implications for hospitality, with research projecting a 6% decline in food and beverage revenues, equivalent to £2.7bn in the UK.

This matters because GLP-1 adoption is unlikely to remain a niche phenomenon. Pill-based treatments are now arriving in UK pharmacies, prices are expected to fall, and wider access is likely over time. As adoption grows, today’s behavioural shifts have the potential to become tomorrow’s commercial reality.

For hospitality businesses, the challenge becomes understanding which customer segments, occasions and revenue streams are most exposed.

Health, value and the rewiring of choice

Health sits at the centre of this shift, becoming the default lens through which decisions are made across both retail and hospitality.

Many GLP-1 users describe a sense of control rather than deprivation, and that mindset carries into how they spend. Clear information, recognisable ingredients and straightforward communication become more powerful than ever, while vague claims and marketing shorthand quickly lose credibility.

These shifts are also reshaping how value is perceived more broadly. Large pack sizes and bulk formats, long associated with value, begin to lose relevance as households align purchases more closely with actual consumption and look to reduce waste. In their place, smaller formats, single-serve options and more flexible packaging gain traction.

And as overall volume declines, consumers show a greater willingness to trade up on the items they do buy. Premiumisation becomes less about indulgence and more about making each choice count, creating space for products that deliver clear functional or experiential benefits.

The same principle applies in hospitality, where consumers are becoming more selective about when they eat out, what they order and what constitutes value from an occasion.

A more intentional model

The challenge isn’t recognising that GLP-1s are changing behaviour. Many businesses already suspect they are.

The real difficulty is isolating that impact from wider economic pressures. Rising costs, inflation and changing consumer confidence all influence performance, making it difficult to determine how much revenue risk is directly linked to GLP-1 adoption.

This makes diagnosis just as important as strategy. Businesses need a clearer understanding of where they are genuinely exposed, which customer groups are changing behaviour and how that compares with competitors. Live exposure models can help businesses understand where GLP-1 adoption presents genuine commercial risk, where new opportunities exist and how their exposure compares with competitors.

What we’re seeing today is still the early phase of adoption of these drugs. But as access expands and behaviour becomes more entrenched, the businesses that succeed will be those that move beyond assumptions and understand precisely where demand is changing. In a market where consumers are buying and eating out less often, growth will come from giving people a better reason to choose, not simply another reason to buy.